List of bibliographic references
Number of relevant bibliographic references: 13.
| Ident. | Authors (with country if any) | Title |
|---|
| 000583 (2012) |
Maxime Dougados [France] ; Karsten Kissel [Suisse] ; Tom Sheeran [Royaume-Uni] ; Paul P. Tak [Pays-Bas] ; Philip G. Conaghan [Royaume-Uni] ; Emilio Martín Mola [Espagne] ; Georg Schett [Allemagne] ; Howard Amital [Israël] ; Federico Navarro-Sarabia [Espagne] ; Antony Hou [États-Unis] ; Corrado Bernasconi [Suisse] ; Twj Huizinga [Pays-Bas] | Adding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders: 24-week symptomatic and structural results of a 2-year randomised controlled strategy trial in rheumatoid arthritis (ACT-RAY) |
| 000591 (2012) |
Vivian P. Bykerk [États-Unis, Canada] ; Andrew J K. Östör [Royaume-Uni] ; José Alvaro-Gracia [Espagne] ; Karel Pavelka [République tchèque] ; José Andrés Román Ivorra [Espagne] ; Winfried Graninger [Autriche] ; William Bensen [Canada] ; Michael T. Nurmohamed [Pays-Bas] ; Andreas Krause [Allemagne] ; Corrado Bernasconi [Suisse] ; Andrea Stancati [Suisse] ; Jean Sibilia [France] | Tocilizumab in patients with active rheumatoid arthritis and inadequate responses to DMARDs and/or TNF inhibitors: a large, open-label study close to clinical practice |
| 000968 (2013) |
John D. Isaacs ; Olivier Harari ; Uwe Kobold ; Janet S. Lee ; Corrado Bernasconi | Effect of tocilizumab on haematological markers implicates interleukin-6 signalling in the anaemia of rheumatoid arthritis. |
| 000A17 (2014) |
Maxime Dougados [France] ; Karsten Kissel [Australie] ; Philip G. Conaghan [Royaume-Uni] ; Emilio Martin Mola [Espagne] ; Georg Schett [Allemagne] ; Roberto Gerli [Italie] ; Michael Sejer Hansen [Danemark] ; Howard Amital [Israël] ; Ricardo M. Xavier [Brésil] ; Orrin Troum [États-Unis] ; Corrado Bernasconi [Suisse] ; T W J. Huizinga [Pays-Bas] | Clinical, radiographic and immunogenic effects after 1 year of tocilizumab-based treatment strategies in rheumatoid arthritis: the ACT-RAY study |
| 000B88 (2014) |
T W J. Huizinga [Pays-Bas] ; Philip G. Conaghan [Royaume-Uni] ; Emilio Martin-Mola [Espagne] ; Georg Schett [Allemagne] ; Howard Amital [Israël] ; Ricardo M. Xavier [Brésil] ; Orrin Troum [États-Unis] ; Maher Aassi ; Corrado Bernasconi ; Maxime Dougados [France] | Clinical and radiographic outcomes at 2 years and the effect of tocilizumab discontinuation following sustained remission in the second and third year of the ACT-RAY study |
| 000D09 (2015) |
Vivian P. Bykerk [États-Unis] ; Andrew J. K. Östör [Royaume-Uni] ; José Alvaro-Gracia [Espagne] ; Karel Pavelka [République tchèque] ; José Andrés Román Ivorra [Espagne] ; Winfried Graninger [Autriche] ; William Bensen ; Michael T. Nurmohamed [Pays-Bas] ; Andreas Krause [Allemagne] ; Corrado Bernasconi [Suisse] ; Maher Aassi [Suisse] ; Jean Sibilia [France] | Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice |
| 000E07 (2015) |
Vivian P. Bykerk [États-Unis] ; Andrew J. K. Östör [Royaume-Uni] ; José Alvaro-Gracia [Espagne] ; Karel Pavelka [République tchèque] ; José Andrés Román Ivorra [Espagne] ; Winfried Graninger [Autriche] ; William Bensen ; Michael T. Nurmohamed [Pays-Bas] ; Andreas Krause [Allemagne] ; Corrado Bernasconi [Suisse] ; Maher Aassi [Suisse] ; Jean Sibilia [France] | Erratum to: Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice |
| 000E36 (2015) |
Maxime Dougados ; Tom W. J. Huizinga ; Ernest H. Choy ; Clifton O. Bingham ; Maher Aassi ; Corrado Bernasconi | Evaluation of the Disease Activity Score in Twenty‐Eight Joints–Based Flare Definitions in Rheumatoid Arthritis: Data From a Three‐Year Clinical Trial |
| 001215 (2016) |
Johannes W J. Bijlsma [Pays-Bas] ; Paco M J. Welsing [Pays-Bas] ; Thasia G. Woodworth [États-Unis] ; Leonie M. Middelink [Pays-Bas] ; Attila Pethö-Schramm [Suisse] ; Corrado Bernasconi [Suisse] ; Michelle E A. Borm [Pays-Bas] ; Cornelis H. Wortel [États-Unis] ; Evert Jan Ter Borg [Pays-Bas] ; Z Nazira Jahangier [Pays-Bas] ; Willemijn H. Van Der Laan [Pays-Bas] ; George A W. Bruyn [Pays-Bas] ; Paul Baudoin [Pays-Bas] ; Siska Wijngaarden [Pays-Bas] ; Petra A J M. Vos [Pays-Bas] ; Reinhard Bos [Pays-Bas] ; Mirian J F. Starmans [Pays-Bas] ; Eduard N. Griep [Pays-Bas] ; Joanna R M. Griep-Wentink [Pays-Bas] ; Cornelia F. Allaart [Pays-Bas] ; Anton H M. Heurkens [Pays-Bas] ; Xavier M. Teitsma [Pays-Bas] ; Janneke Tekstra [Pays-Bas] ; Anne Carien A. Marijnissen [Pays-Bas] ; Floris P J. Lafeber [Pays-Bas] ; Johannes W G. Jacobs [Pays-Bas] | Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double-dummy, strategy trial. |
| 001589 (????) |
Bolous Haraoui [Canada] ; Gustavo Casado [Argentine] ; Laszlo Czirják [Hongrie] ; Andrew Taylor [Australie] ; Corrado Bernasconi [Suisse] ; William Reiss [Suisse] ; Roberto Caporali [Italie] | Patterns of tocilizumab use, effectiveness and safety in patients with rheumatoid arthritis: core data results from a set of multinational observational studies. |
| 001623 (2017) |
Ernest H. Choy [Royaume-Uni] ; Corrado Bernasconi [Suisse] ; Maher Aassi [Suisse] ; Jose Fernando Molina [Colombie] ; Oscar Massimiliano Epis [Italie] | Treatment of Rheumatoid Arthritis With Anti-Tumor Necrosis Factor or Tocilizumab Therapy as First Biologic Agent in a Global Comparative Observational Study. |
| 001859 (2017) |
Ernest Choy [Royaume-Uni] ; Roberto Caporali [Italie] ; Ricardo Xavier [Brésil] ; Bruno Fautrel [France] ; Raim N Sanmarti [Espagne] ; Min Bao [États-Unis] ; Corrado Bernasconi [Suisse] ; Attila Pethö-Schramm [Suisse] | Subcutaneous tocilizumab in rheumatoid arthritis: findings from the common-framework phase 4 study programme TOZURA conducted in 22 countries |
| 001A31 (2018) |
Ernest Choy [Royaume-Uni] ; Roberto Caporali [Italie] ; Ricardo Xavier [Brésil] ; Bruno Fautrel [France] ; Raim N Sanmarti [Espagne] ; Min Bao [États-Unis] ; Corrado Bernasconi [Suisse] ; Attila Pethö-Schramm [Suisse] | Subcutaneous tocilizumab in rheumatoid arthritis: findings from the common-framework phase 4 study programme TOZURA conducted in 22 countries |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Ncbi/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i -k "Corrado Bernasconi"
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i \
-Sk "Corrado Bernasconi" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= TocilizumabV1
|flux= Ncbi
|étape= Checkpoint
|type= indexItem
|index= Author.i
|clé= Corrado Bernasconi
}}
| This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021 |  |
